Key result
E-4031 increases AF threshold in guinea pigs but is less potent than class I antiarrhythmics.
Why the study?
Does E-4031 improve atrial fibrillation threshold, effective refractory period, and interatrial conduction time in guinea pig hearts compared to class I antiarrhythmic agents?
Does E-4031 improve atrial fibrillation threshold, effective refractory period, and interatrial conduction time in guinea pig hearts compared to class I antiarrhythmic agents?
In guinea pig hearts, E-4031 exerts an antifibrillatory effect by prolonging atrial ERP alone, but is less potent than class I drugs that also affect conduction time.
Answers are grounded in this paper and cite their sources.
E-4031's ERP-mediated antifibrillatory action is less potent than class I agents in guinea pigs; leaves open class selection for human AF.
The effects of E-4031, a new class III antiarrhythmic agent, on atrial fibrillation threshold (AFT), atrial effective refractory period (ERP), and interatrial conduction time (ACT) were investigated in Langendorff-perfused guinea pig hearts; the results were then compared with those of the class I agents disopyramide, procainamide, lidocaine, and flecainide. Whole guinea pig hearts were perfused with Tyrode's solution containing acetylcholine (ACh 3 x 10(-7) M). The three indexes were measured before and after administration of the test drugs, using right atrial extrastimulus and 50-Hz continuous stimulation. Disopyramide, procainamide, and flecainide (> or = 10(-6) M) significantly increased AFT. Although E-4031 (> or = 3 x 10(-6) M) also increased AFT, this effect was less potent than that observed with the other drugs. E-4031 (> or = 10(-6) M) significantly prolonged ERP, and this prolongation was less pronounced than that observed with disopyramide but similar to that observed with procainamide or flecainide. E-4031 did not affect ACT, and the greatest prolongation of ACT was observed with flecainide. Lidocaine had no effect on any of the indexes. These findings suggest that in guinea pig hearts E-4031 exerts an antifibrillatory effect by prolonging atrial ERP alone, but this effect is less pronounced than that observed with class I drugs, because AFT measured by 50-Hz continuous stimulation is influenced by both ERP and ACT.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (1994) studied Atrial fibrillation (experimental model). E-4031 vs. Class I agents (disopyramide, procainamide, lidocaine, and flecainide) was evaluated on Atrial fibrillation threshold (AFT), atrial effective refractory period (ERP), and interatrial conduction time (ACT). In guinea pig hearts, E-4031 increased atrial fibrillation threshold and prolonged atrial effective refractory period, but its antifibrillatory effect was less potent than class I antiarrhythmic drugs.
Synapse has enriched 10 related papers. Consider them for comparative context: